Silencing of GRP78 resulted in a suppression of CRC growth by the downregulation of vascular endothelial growth factor receptor-2/vascular endothelial growth factor (VEGFR2/VEGF) pathway16. This evidence concerns the gene VEGFA and colorectal carcinoma.